It has recently been demonstrated that the low binding affinity of PAI-2 for endocytic receptors facilitates the clearance of uPA without evoking downstream signaling events, providing a possible explanation for the inhibitory role of PAI-2 in cancer progression [28,40]. This evidence concerns the gene PLAU and cancer.